Company / Goodwill
Veracyte, Inc. Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$767.2M
FY2025
5-year range
$695.9M / $767.2M
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#73 of 141
Health Care
What the data says
At $767M, Veracyte, Inc.'s goodwill ranks #73 of 141 in the Health Care sector. Goodwill has increased for 3 consecutive years, from $696M in FY2022 to $767M in FY2025.
Based on SEC 10-K filings.
$767M in FY2025 with a 5-year CAGR of +209.0%.
Improved from $703M to $767M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +3.3%
- 5-Year CAGR
- +209.0%
- 10-Year CAGR
- -
Sector benchmark
#73 of 141 in Health CareTop 52% of 141This company $767.2M Sector average $5.4B
▼
-85.7% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s goodwill has grown for 3 consecutive years.
- 5-year CAGR of +209.0%, indicating consistent growth.
- In FY2025, goodwill increased 2.9% year-over-year.
- Ranks #73 out of 141 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $767.2M | +2.9% |
| FY2024 | $745.8M | +6.1% |
| FY2023 | $703.0M | +1.0% |
| FY2022 | $695.9M | -1.7% |
| FY2021 | $707.9M | +25878.1% |
| FY2020 | $2.7M | +0.0% |
| FY2019 | $2.7M | +157.8% |
| FY2018 | $1.1M | +0.0% |
| FY2017 | $1.1M | +0.0% |
| FY2016 | $1.1M | +0.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026